AChR | Surface AChR (fmol 125I-mAb 295 binding site/oocyte) | Total currenta (μA) | Specific activity (current/surface AChR) (μA/fmol mAb 295 binding) | Relative specific activityb to wild-type α4β2(1:1) |
---|---|---|---|---|
α4β2(1:1) | 11.4±1.23 | 2.42±0.15 | 0.21 | 1.0 |
α-12-β | 0.94±0.11 | 1.39±0.07 | 1.47 | 6.9 |
α-12-β + α4 | 2.79±0.27 | 6.42±0.34 | 2.31 | 10.9 |
α-12-β + β2 | 2.74±0.23 | 0.11±0.01 | 0.04 | 0.2 |
β-6-α | 1.01±0.15 | 1.75±0.09 | 1.72 | 8.1 |
β-6-α + α4 | 3.09±0.27 | 7.29±0.44 | 2.36 | 11.1 |
β-6-α + β2 | 5.20±0.63 | 1.30±0.08 | 0.25 | 1.2 |
α-6-β | 2.05±0.79 | 0.13±0.02 | 0.06 | 0.3 |
α-6-β + α4 | 2.70±0.74 | 1.38±0.31 | 0.51 | 2.4 |
α-6-β + β2 | 4.19±1.90 | 0.17±0.05 | 0.04 | 0.2 |
β-α | 0.06±0.01 | 0.02±0.00 | 0.27 | 1.3 |
β-α + α4 | 0.49±0.07 | 0.36±0.05 | 0.73 | 3.5 |
β-α + β2 | 0.60±0.09 | 0.16±0.02 | 0.26 | 1.2 |